Ustekinumab (Brand name: Stelara) a human monoclonal antibody which blocks the p40 subunit of IL-12 and IL-23 is the new biologics approved for the treatment of moderate to severe psoriasis. Stelara is new biologics for psoriasis indicated for those who ...